Skip to main content

Selling the Story of a Discovery

Magnus Höök, a professor at Texas A&M, worked for more than 20 years perfecting an antibody that attacks protein adhesins on bacterial surfaces. But when Höök and his colleagues sought to move their trademark proteins into the market, he says his "lack of knowledge" surprised him. "You start out thinking this is a cool idea, and it would be useful," Höök relates. Höök is a director at Inhibitex Inc., an Alpharetta, Ga.-based company that is now testin

Written byPaula Park
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

Many scientists loathe any association with such commercial considerations Höök observes, and indeed, even Lita Nelson, director of the Technology Licensing Office of the Massachusetts Institute of Technology, takes pains to distance academic enterprise from pure entrepreneurship. "Most universities see technology transfer primarily as a way of getting very early stage technology invested in," she says. "They recognize the high risk. It is not primarily a money-making proposition for most universities, ... but instead a way of getting their funding for basic research into practical use by the public."

Editor's Note: Parts 2 and 3 of Taking a Discovery to Market will appear in the Nov. 26 and Dec. 10 issues.

But product development requires private finance. Before Höök could get development funds, he had to replace his focus on the basic research with an emphasis on the story, the market-based justification of investment in an innovation. That story can ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays